Janssen Research & Development

The US Food and Drug Administration has approved a new treatment (Elreada) for patients with prostate cancer that is non-metastatic but continues to grow despite being treated with hormone therapy. Read more


Johnson & Johnson Innovation (J&J Innovation) and Janssen Research and Development have announced the launch of the World Without Disease QuickFire challenge for disease solutions from across the pharmaceutical, medical device and consumer sectors Read more


Participating companies are AstraZeneca, GSK, Janssen R&D, Lilly, Pfizer, Takeda and UCB. Read more